Stem cell treatment for rheumatoid arthritis is an experimental approach currently under investigation. Rheumatoid arthritis is a chronic autoimmune disease that affects the joints, causing inflammation and damage to joint tissue. Stem cell treatment focuses on using the regenerative and immune-modulating properties of stem cells to address the symptoms and inflammation associated with this disease.
One way stem cell treatment for rheumatoid arthritis is being researched is through the use of mesenchymal stem cell therapy. These cells can be sourced from various places, including the patient’s own bone marrow, adipose tissue, or allogeneic sources like umbilical cord tissue. It has been theorized that these cells may have the ability to modulate the immune response and reduce inflammation in the joints.
However, it’s important to note that stem cell treatment for rheumatoid arthritis is still in an early stage of research and is not considered a conventional therapy. More rigorous clinical studies are needed to determine the safety and efficacy of this therapy in the long-term treatment of rheumatoid arthritis.
Conventional treatments for rheumatoid arthritis typically include non-steroidal anti-inflammatory drugs (NSAIDs), disease-modifying antirheumatic drugs (DMARDs), and biologic therapies, which are used to control symptoms, reduce inflammation, and prevent joint damage.
We are aware that despite the use of medications, they can have devastating side effects, without perfect control of the disease, which is why cellular medicine is a promising therapy that does not have these side effects, but rather is beneficial, and can even repair tissues that have been affected by the use of treatment to control the disease.
